Approval of New Patch Tests for the Diagnosis of Allergic Contact Dermatitis
An FDA Public Workshop.
Rabin RL, Aquino M, Atwater AR, Belsito D, Brod BA, Chen J, DeKoven J, Ehrlich A, Fonacier L, Fowler J, Hamann C, Lu Y, Mahler V, Pacheco K, Taylor JS, Warshaw E, Flamm A, Yu J
DermatitisIn the feed 8 Oct 2026, published online 7 Oct 2026, issue 2026 Sep-Oct, added to PubMed 8 Oct 2026
Topics: Contact dermatitis
Abstract
Contact dermatitis (CD) is the 5th most common skin disease1 and affects 15-20% of the general population over their lifetimes.2 Currently, the T.R.U.E. TEST® is the only FDA-approved diagnostic product to aid in the diagnosis of Allergic Contact Dermatitis. To address that diagnostic gap, the US Food and Drug Administration held a public workshop in October 2025. These proceedings summarize the workshop presentations and discussions.
Abstract from PubMed
PMID 42844652 · DOI 10.1177/17103568261468630